Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Ketroussi, Farah ^a   Giuliani, Massimo ^a   Bahri, Rajia ^a   Azzarone, Bruno ^a   Charpentier, Bernard ^a,b   Durrbach, Antoine ^a,b  

^a INSERM U1014   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HLA G ANTIGEN; LILRB1 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; MTOR PROTEIN, HUMAN; OKT 3; PTPN11 PROTEIN, HUMAN; S6 KINASE; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

ANTIGENS, CD; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HLA-G ANTIGENS; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MUROMONAB-CD3; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS; TOR SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC;

EID: 80051973196     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022776     Document Type: Article

References (37)

1. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR, (1997) Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186 (2): 289-98.
2. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED, (2003) Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64 (11): 1039-44.
3. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED, (1997) The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A 94 (10): 5249-54.
4. Créput C, Durrbach A, Menier C, Guettier C, Samuel D, et al. (2003) HLA-G expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 39 (4): 587-594.
5. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, et al. (2002) Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105 (16): 1949-54.
6. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, et al. (2000) Implication of HLA-G molecule in heart-graft acceptance. Lancet 355 (9221): 2138.
7. Brugiere O, Thabut G, Pretolani M, Krawice-Radanne I, Dill C, et al. (2009) Immunohistochemical study of HLA-G expression in lung transplant recipients. Am J Transplant 9 (6): 1427-38.
8. Riteau B, Menier C, Khalil-Daher I, Martinozzi S, Pla M, et al. (2001) HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol 13 (2): 193-201.
9. Sumimoto R, Kamada N, (1990) Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 50 (4): 678-82.
10. Chiang YJ, Lu L, Fung JJ, Qian S, (2001) Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant 10 (3): 343-50.
11. Dorling A, Monk NJ, Lechler RI, (2000) HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 30 (2): 586-93.
12. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, et al. (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11 (8): 1351-6.
13. Puppo F, Contini P, Ghio M, Indiveri F, (2002) Soluble HLA Class I Molecules/CD8 Ligation Trigger Apoptosis of CD8+ Cells by Fas/Fas-Ligand Interaction. Scientific World Journal 2 (2): 421-3.
14. Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, et al. (2007) CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T cell subsets involved in transplant acceptance. Blood.
15. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, et al. (1999) HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 43 (2): 203-211.
16. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED, (2001) Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 98 (21): 12150-5.
17. Bainbridge DR, Ellis SA, Sargent IL, (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 48 (1): 17-26.
18. Liang S, Horuzsko A, (2003) Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 64 (11): 1025-32.
19. Le Friec G, Laupeze B, Fardel O, Sebti Y, Pangault C, et al. (2003) Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol 64 (8): 752-61.
20. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, et al. (2000) Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164 (12): 6100-4.
21. Contini P, Ghio M, Poggi A, Filaci G, Indiver F, et al. (2003) Soluble HLA-A,-B,-C and-G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33 (1): 125-34.
22. Rajagopalan S, Long EO, (1999) A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (7): 1093-100.
23. Colonna M, (1997) Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 155: 127-33.
24. Cosman D, Fanger N, Borges L, Kubin M, Chin W, et al. (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (2): 273-82.
25. Saverino D, Fabbi M, Ghiotto F, Merio A, Bruno S, et al. (2000) The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol 165 (7): 3742-55.
26. Chapman TL, Heikeman AP, Bjorkman PJ, (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11 (5): 603-13.
27. Fan QR, Long EO, Wiley DC, (2001) Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2 (5): 452-60.
28. Bellon T, Kitzig F, Sayos J, Lopez-Botet M, (2002) Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 168 (7): 3351-9.
29. Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, et al. (1998) The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol 28 (11): 3423-34.
30. Le Rond S, Le Maoult J, Creput C, Menier C, Deschamps M, et al. (2004) Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: In vivo implications in transplanted patients. Eur J Immunol 34 (3): 649-660.
31. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, et al. (2000) Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5,-G6, and-G7 transcripts in human transfected cells. Hum Immunol 61 (11): 1138-49.
32. Le Rond S, Azema C, Krawice-Radanne I, Durrbach A, Guettier C, et al. (2006) Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 176 (5): 3266-76.
33. Chen L, Sung SS, Yip ML, Lawrence HR, Ren Y, et al. (2006) Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol 70 (2): 562-70.
34. Liang S, Ristich V, Arase H, Dausset J, Carosell ED, et al. (2008) Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci U S A 105 (24): 8357-62.
35. Christophi GP, Hudson CA, Gruber RC, Christophi CP, Mihai C, et al. (2008) SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest 88 (3): 243-55.
36. Lorenz U, (2009) SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev 228 (1): 342-59.
37. Morandi F, Ferretti E, Bocca P, Prigione I, Raffaghello L, et al. (2010) A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. PLoS One 5 (7): e11763.